Martínez F, Nielsen H, Johansson L. "一种的合成方法" [P]. European Patent, EP 3252537 A1, 2025-02-25.
发明人沈红梅,冯建国,周伟. "Method for the Synthesis of 1-(5-Isopropyl-1,3,4-thiadiazol-2-yl)-3-(3-methoxyphenyl)urea" [P]. 中国发明专利, 专利号 CN 115559431 B, 授权公告日 2022-03-28.
Fischer A B, Roberts E F, Schröder R. "A Process for Preparing High-Purity 1-(5-Isopropyl-1,3,4-thiadiazol-2-yl)-3-(3-methoxyphenyl)urea" [P]. US Patent, US 11418865 B2, 2016-01-08.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2019, 960, (1), 3643-3647.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2020, 2480, (2), 6113-6118.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 1-(5-Isopropyl-1,3,4-thiadiazol-2-yl)-3-(3-methoxyphenyl)urea Using HRMS and NMR". Talanta, 2017, 918, (8), 8032-8036.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2010, 571, (1), 9904-9921.